Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: September 02, 2026
Ruxolitinib and heart failure outcomes among patients with myelofibrosis.
Journal: Leukemia & lymphoma
Published: March 05, 2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.
Journal: British journal of haematology
Published: December 08, 2025
Risk factors associated with high probability of pulmonary hypertension in patients with myeloproliferative neoplasms.
Journal: International journal of hematology
Published: December 02, 2025
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis.
Journal: Cardio-oncology (London, England)
Published: November 17, 2025
Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms.
Journal: Circulation. Cardiovascular imaging
Published: June 10, 2025
Outcomes of patients with myeloproliferative neoplasms and critical limb ischemia: insights from the National readmissions database.
Journal: Journal of thrombosis and thrombolysis
Published: March 17, 2025
Last Updated: 09/26/2026